{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:16:35Z","timestamp":1707524195585},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,1,30]]},"DOI":"10.7759\/cureus.13014","type":"journal-article","created":{"date-parts":[[2021,1,30]],"date-time":"2021-01-30T19:49:25Z","timestamp":1612036165000},"source":"Crossref","is-referenced-by-count":0,"title":["Ocular Toxoplasmosis Mimicking Lymphoma: Exploring the Correlation and Distinction"],"prefix":"10.7759","author":[{"given":"Omid","family":"Yazdanpanah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lea M","family":"Monday","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarvani","family":"Surapaneni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijendra","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Chi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-9071.2012.02838.x","article-title":"Ocular toxoplasmosis II: clinical features, pathology and management","volume":"41","author":"Butler NJ","year":"2013","unstructured":"Butler NJ, Furtado JM, Winthrop KL, Smith JR. Ocular toxoplasmosis II: clinical features, pathology and management. Clin Exp Ophthalmol. 2013, 41:95-108. 10.1111\/j.1442-9071.2012.02838.x","journal-title":"Clin Exp Ophthalmol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-10-883124","article-title":"Intraocular toxoplasmosis mimicking vitreous lymphoma","volume":"133","author":"Su RJ","year":"2019","unstructured":"Su RJ, Said J. Intraocular toxoplasmosis mimicking vitreous lymphoma. Blood. 2019, 133:767. 10.1182\/blood-2018-10-883124","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2015.08.033","article-title":"The role of chorioretinal biopsy in the diagnosis of intraocular lymphoma","volume":"160","author":"Mastropasqua R","year":"2015","unstructured":"Mastropasqua R, Thaung C, Pavesio C, et al.. The role of chorioretinal biopsy in the diagnosis of intraocular lymphoma. Am J Ophthalmol. 2015, 160:1127-1132.e1. 10.1016\/j.ajo.2015.08.033","journal-title":"Am J Ophthalmol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1159\/000449169","article-title":"Recent developments in the diagnosis and treatment of ocular toxoplasmosis","volume":"57","author":"Ozgonul C","year":"2017","unstructured":"Ozgonul C, Besirli CG. Recent developments in the diagnosis and treatment of ocular toxoplasmosis. Ophthalmic Res. 2017, 57:1-12. 10.1159\/000449169","journal-title":"Ophthalmic Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2003.10.032","article-title":"Ocular toxoplasmosis: a global reassessment: part II: disease manifestations and management","volume":"137","author":"Holland GN","year":"2004","unstructured":"Holland GN. Ocular toxoplasmosis: a global reassessment: part II: disease manifestations and management. Am J Ophthalmol. 2004, 137:1-17. 10.1016\/j.ajo.2003.10.032","journal-title":"Am J Ophthalmol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9394(14)73641-4","article-title":"Progressive ocular toxoplasmosis in patients with acquired immunodeficiency syndrome","volume":"115","author":"Moorthy RS","year":"1993","unstructured":"Moorthy RS, Smith RE, Rao NA. Progressive ocular toxoplasmosis in patients with acquired immunodeficiency syndrome. Am J Ophthalmol. 1993, 115:742-747. 10.1016\/s0002-9394(14)73641-4","journal-title":"Am J Ophthalmol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-08-764712","article-title":"How I treat CLL patients with ibrutinib","volume":"131","author":"Brown JR","year":"2018","unstructured":"Brown JR. How I treat CLL patients with ibrutinib. Blood. 2018, 131:379-386. 10.1182\/blood-2017-08-764712","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofx163.1876","article-title":"Opportunistic infections (OIs) in patients with hematologic malignancies (HM) treated with Bruton\u2019s tyrosine kinase (BTK) and phosphoinositide 3 kinase (PI3K) inhibitors: an 8-year retrospective cohort study","volume":"4","author":"Issa N","year":"2017","unstructured":"Issa N, Arbona-Haddad E, Nevett-Fernandez A, et al.. Opportunistic infections (OIs) in patients with hematologic malignancies (HM) treated with Bruton\u2019s tyrosine kinase (BTK) and phosphoinositide 3 kinase (PI3K) inhibitors: an 8-year retrospective cohort study. Open Forum Infect Dis. 2017, 4:S699. 10.1093\/ofid\/ofx163.1876","journal-title":"Open Forum Infect Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2013.12.001","article-title":"Primary intraocular lymphoma","volume":"59","author":"Sagoo MS","year":"2014","unstructured":"Sagoo MS, Mehta H, Swampillai AJ, Cohen VML, Amin SZ, Plowman PN, Lightman S. Primary intraocular lymphoma. Surv Ophthalmol. 2014, 59:503-516. 10.1016\/j.survophthal.2013.12.001","journal-title":"Surv Ophthalmol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.82.3.245","article-title":"Increased presence of Epstein-Barr virus DNA in ocular fluid samples from HIV negative immunocompromised patients with uveitis","volume":"82","author":"Ongkosuwito JV","year":"1998","unstructured":"Ongkosuwito JV, Van der Lelij A, Bruinenberg M, et al.. Increased presence of Epstein-Barr virus DNA in ocular fluid samples from HIV negative immunocompromised patients with uveitis. Br J Ophthalmol. 1998, 82:245-251. 10.1136\/bjo.82.3.245","journal-title":"Br J Ophthalmol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3880424","article-title":"Detection of Toxoplasma gondii DNA in primary intraocular B-cell lymphoma","volume":"14","author":"Shen DF","year":"2001","unstructured":"Shen DF, Herbort CP, Tuaillon N, Buggage RR, Egwuagu CE, Chan CC. Detection of Toxoplasma gondii DNA in primary intraocular B-cell lymphoma. Mod Pathol. 2001, 14:995-999. 10.1038\/modpathol.3880424","journal-title":"Mod Pathol"},{"key":"ref12","article-title":"Molecular pathology of primary intraocular lymphoma","volume":"101","author":"Chan CC","year":"2003","unstructured":"Chan CC. Molecular pathology of primary intraocular lymphoma. Trans Am Ophthalmol Soc. 2003, 101:275-292.","journal-title":"Trans Am Ophthalmol Soc"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21191","article-title":"Analysis of clonal immunoglobulin heavy chain rearrangements in ocular lymphoma","volume":"104","author":"Baehring JM","year":"2005","unstructured":"Baehring JM, Androudi S, Longtine JJ, Betensky RA, Sklar J, Foster CS, Hochberg FH. Analysis of clonal immunoglobulin heavy chain rearrangements in ocular lymphoma. Cancer. 2005, 104:591-597. 10.1002\/cncr.21191","journal-title":"Cancer"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2018.2887","article-title":"Potential diagnosis of vitreoretinal lymphoma by detection of MYD88 mutation in aqueous humor with ultrasensitive droplet digital polymerase chain reaction","volume":"136","author":"Hiemcke-Jiwa LS","year":"2018","unstructured":"Hiemcke-Jiwa LS, ten Dam-van Loon N, Leguit RJ, et al.. Potential diagnosis of vitreoretinal lymphoma by detection of MYD88 mutation in aqueous humor with ultrasensitive droplet digital polymerase chain reaction. JAMA Ophthalmol. 2018, 136:1098-1104. 10.1001\/jamaophthalmol.2018.2887","journal-title":"JAMA Ophthalmol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2598","article-title":"Primary central nervous system lymphoma: a curable disease","volume":"37","author":"Batchelor TT","year":"2019","unstructured":"Batchelor TT. Primary central nervous system lymphoma: a curable disease. Hematol Oncol. 2019, 37:15-18. 10.1002\/hon.2598","journal-title":"Hematol Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2017.1332769","article-title":"False negative Toxoplasma serology in an immunocompromised patient with PCR positive ocular toxoplasmosis","volume":"26","author":"Rajput R","year":"2018","unstructured":"Rajput R, Denniston AK, Murray PI. False negative Toxoplasma serology in an immunocompromised patient with PCR positive ocular toxoplasmosis. Ocul Immunol Inflamm. 2018, 26:1200-1202. 10.1080\/09273948.2017.1332769","journal-title":"Ocul Immunol Inflamm"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9394(02)01526-x","article-title":"An update on current practices in the management of ocular toxoplasmosis","volume":"134","author":"Holland GN","year":"2002","unstructured":"Holland GN, Lewis KG. An update on current practices in the management of ocular toxoplasmosis. Am J Ophthalmol. 2002, 134:102-114. 10.1016\/s0002-9394(02)01526-x","journal-title":"Am J Ophthalmol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007417.pub3","article-title":"Corticosteroids as adjuvant therapy for ocular toxoplasmosis","volume":"1","author":"Jasper S","year":"2017","unstructured":"Jasper S, Vedula SS, John SS, Horo S, Sepah YJ, Nguyen QD. Corticosteroids as adjuvant therapy for ocular toxoplasmosis. Cochrane Database Syst Rev. 2017, 1:007417. 10.1002\/14651858.CD007417.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19800215)45:4<688::aid-cncr2820450412>3.0.co;2-f","article-title":"The role of radiation therapy in the management of ocular reticulum cell sarcoma","volume":"45","author":"Margolis L","year":"1980","unstructured":"Margolis L, Fraser R, Lichter A, Char DH. The role of radiation therapy in the management of ocular reticulum cell sarcoma. Cancer. 1980, 45:688-692. 10.1002\/1097-0142(19800215)45:4&lt;688::aid-cncr2820450412&gt;3.0.co;2-f","journal-title":"Cancer"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000461333.55612.f2","article-title":"High-dose methotrexate with or without rituximab in newly diagnosed primary CNS lymphoma","volume":"84","author":"Chamberlain MC","year":"2015","unstructured":"Chamberlain MC. High-dose methotrexate with or without rituximab in newly diagnosed primary CNS lymphoma. Neurology. 2015, 84:758-759. 10.1212\/01.wnl.0000461333.55612.f2","journal-title":"Neurology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/50514-ocular-toxoplasmosis-mimicking-lymphoma-exploring-the-correlation-and-distinction","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:29:30Z","timestamp":1707506970000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/50514-ocular-toxoplasmosis-mimicking-lymphoma-exploring-the-correlation-and-distinction"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,30]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.13014","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1,30]]}}}